The Discounted Cash Flow (DCF) valuation of ChromoGenics AB (CHRO.ST) is (2,297.41) SEK. With the latest stock price at 9.78 SEK, the upside of ChromoGenics AB based on DCF is -23590.9%.
Based on the latest price of 9.78 SEK and our DCF valuation, ChromoGenics AB (CHRO.ST) is a sell. selling CHRO.ST stocks now will result in a potential gain of 23590.9%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 4.2% - 5.3% | 4.7% |
| Long-term Growth Rate | 3.0% - 3.8% | 3.4% |
| Fair Price | (7,757.16) - (1,360.19) | (2,297.41) |
| Upside | -79416.5% - -14007.9% | -23590.9% |